Betamethasone Dipropionate Ointment, Augmented
Product Images NDC 59651-699

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Betamethasone Dipropionate (NDC 59651-699). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label.principal Display Panel (15 g Tube Label)

Label for Betamethasone Dipropionate Ointment USP (Augmented) 0.05% topical ointment, 15 g package, distributed by Aurobindo Pharma USA, Inc. Contains dosage strength, usage instructions, storage conditions, and barcode. Not for oral, ophthalmic, or intravaginal use.*

FDA Label Image

Package Label.principal Display Panel (15 g Tube Carton Label)

Packaging label for Betamethasone Dipropionate Ointment, USP (Augmented) 0.05% topical ointment. The label indicates the product is for prescription use only, contains 15 grams per package, and is distributed by Aurobindo Pharma USA, Inc. It includes usage instructions, dosage information, and storage conditions, with warnings against oral, ophthalmic, or intravaginal use.*

FDA Label Image

Str (Betamethasonestr)

Chemical structure of betamethasone dipropionate showing its steroid backbone with fluorine substitution and two acetate ester groups attached.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.